For the Inventor, By the Inventor

Enter assignee name

Winnipeg, Canada

Kane Biotech Inc.

USPTO Granted Patents = 13

% Expired Patents = 30.8

EPO Patents = 6

Trademarks = 6

Forward Citations = 124

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Srinivasa Madhyastha (13 out of 14 patents)

Karen Lovetri (9 out of 9 patents)

Purushottam V Gawande (8 out of 8 patents)

4. Nandadeva Yakandawala (8 out of 8 patents)

5. Gord Froehlich (5 out of 5 patents)

6. Jeffrey B Kaplan (2 out of 8 patents)

7. Gordon Froehlich (1 out of 1 patent)

8. Gordon Froelich (1 out of 1 patent)

9. Nanda Yakandawala (1 out of 1 patent)

10. Daniel Rhoads (1 out of 1 patent)

11. Lasha Gogokhia (1 out of 1 patent)

12. Purusbottam Gawande (1 out of 1 patent)

13. Dennis G Cvitkovitch (1 out of 2 patents)

14. Gord Froelich (0 patent)

13 patents: Sort by Forward Citations

1. 11723852 - Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products (2023-08-15),

2. 11103433 - Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products (2021-08-31),

3. 11090366 - Compositions and methods for reducing oral biofilm (2021-08-17),

4. 10357470 - Antimicrobial-antibiofilm compositions and methods of use thereof (2019-07-23),

5. 9980497 - Antimicrobial-antibiofilm compositions and methods of use thereof (2018-05-29),

6. 9622481 - Biofilm-removing antimicrobial compositions and uses thereof (2017-04-18),

7. 8906364 - Antimicrobial compositions and uses thereof (2014-12-09),

8. 8821862 - Soluble β-N-acetylglucosaminidase based antibiofilm compositions and uses thereof (2014-09-02),

9. 8753692 - Biofilm-removing antimicrobial compositions and uses thereof (2014-06-17),

10. 8617542 - DispersinB™, 5-fluorouracil, deoxyribonuclease I and proteinase K-based antibiofilm compositions and uses thereof (2013-12-31),

11. 7556807 - Signal peptides, nucleic acid molecules and methods for treatment of caries (2009-07-07),

12. 7314857 - Synergistic antimicrobial compositions and methods of inhibiting biofilm formation (2008-01-01),

13. 7144992 - Synergistic antimicrobial compositions and methods for reducing biofilm formation (2006-12-05),

Company Overview

Kane Biotech Inc. is a biotechnology company based in Winnipeg, Canada, specializing in the development of innovative solutions for biofilm-related issues. The company focuses on creating products that harness the power of natural antimicrobial agents to address challenges in various sectors, including healthcare and consumer products. Through its proprietary technologies, Kane Biotech aims to enhance the efficacy of treatments and improve product performance, positioning itself as a leader in the field of biotechnology and biofilm management.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#14 in Winnipeg

#1,164 in Canada

#45,039 in the World

Winnipeg, Canada

Kane Biotech Inc.

Forward Citations = 124

13 inventors:

Srinivasa Madhyastha (13 out of 14 patents)

Karen Lovetri (9 out of 9 patents)

Purushottam V Gawande (8 out of 8 patents)

4. Nandadeva Yakandawala (8 out of 8 patents)

5. Gord Froehlich (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kane Biotech Inc.. Retrieved from https://idiyas.com/company/kane-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…